Elena Libhaber to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Elena Libhaber has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0,678
-
Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system. J Hum Hypertens. 2005 Aug; 19(8):659-61.
Score: 0,251
-
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. Am J Hypertens. 2004 May; 17(5 Pt 1):428-32.
Score: 0,230
-
Functional variants of the angiotensinogen gene determine antihypertensive responses to angiotensin-converting enzyme inhibitors in subjects of African origin. J Hypertens. 2006 Jun; 24(6):1057-64.
Score: 0,066
-
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A?single-center study. Endocrinol Diabetes Metab. 2023 01; 6(1):e391.
Score: 0,052
-
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med. 2001 Apr 09; 161(7):965-71.
Score: 0,047
-
Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008 Sep; 10(9):861-8.
Score: 0,019
-
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial. Circulation. 2002 Feb 19; 105(7):830-6.
Score: 0,012